Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial (Q42242013)
Jump to navigation
Jump to search
scientific article published on November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial |
scientific article published on November 2013 |
Statements
1 reference
Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial (English)
1 reference
1 reference
Stefan Zeuzem
1 reference
Edward Gane
1 reference
Peter Ferenci
1 reference
Graham R Foster
1 reference
Michael W Fried
1 reference
Christophe Hezode
1 reference
Ira Jacobson
1 reference
Paul J Pockros
1 reference
Jane Scott
1 reference
Oliver Lenz
1 reference
Monika Peeters
1 reference
Vanitha Sekar
1 reference
Goedele De Smedt
1 reference
Rekha Sinha
1 reference
Maria Beumont-Mauviel
1 reference
1 November 2013
1 reference
1 reference
146
1 reference
2
1 reference
430-41.e6
1 reference
Identifiers
1 reference
1 reference